ANSBERT GADICKE

Insider Reports History

Location
Boston, MA
Signature
/s/ Ansbert Gadicke
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by ANSBERT GADICKE:

Company Role Class Num Shares Value Price $ Report Date Ownership
Harpoon Therapeutics, Inc. 10%+ Owner Common Stock 6,328,095 $145,546,185 $23.00 02 Jun 2021 Indirect
Cullinan Oncology, Inc. Director Common Stock 7,648,268 $95,297,419 $12.46 31 Dec 2021 Indirect
iTeos Therapeutics, Inc. Former 10% Owner Common Stock 3,452,797 $27,829,543 $8.06 13 May 2025 Indirect
Allovir, Inc. Director, 10%+ Owner Common Stock 16,674,766 $11,185,433 $0.6708 28 Jul 2022 By ElevateBio LLC
Repare Therapeutics Inc. 10%+ Owner Common Shares 3,882,485 $9,415,026 $2.42 12 Jul 2021 Indirect
Cullinan Oncology, Inc. Director Common Stock 595,489 $7,419,793 $12.46 21 Dec 2021 Direct
Werewolf Therapeutics, Inc. Former 10% Owner Common Stock 4,784,111 $4,640,587 $0.9700 04 Dec 2025 Indirect
Allovir, Inc. Director, 10%+ Owner Common Stock 30,197 $20,256 $0.6708 28 Jul 2022 Direct
Aktis Oncology, Inc. 10%+ Owner Common Stock 10,260,064 12 Jan 2026 Indirect
Aktis Oncology, Inc. 10%+ Owner Series A Redeemable Convertible Preferred Stock 0 12 Jan 2026 Indirect
Aktis Oncology, Inc. 10%+ Owner Series B Redeemable Convertible Preferred Stock 0 12 Jan 2026 Indirect
Aktis Oncology, Inc. 10%+ Owner Series Seed Redeemable Convertible Preferred Stock 0 12 Jan 2026 Indirect
Cullinan Oncology, Inc. Director Stock Option (Right to Buy) 0 21 Dec 2021 Direct
TCR2 THERAPEUTICS INC. Director, 10%+ Owner Common Stock 0 $1.72 01 Jun 2023 Indirect
TCR2 THERAPEUTICS INC. Director, 10%+ Owner Common Stock Warrant (Right to Buy) 0 22 May 2023 Indirect
Werewolf Therapeutics, Inc. Former 10% Owner Warrant (Right to Buy) 0 27 Mar 2025 Indirect

Insider Reports Filed by ANSBERT GADICKE

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AKTS Aktis Oncology, Inc. 12 Jan 2026 7 +$20,029,986 4 10%+ Owner 14 Jan 2026, 18:17
AKTS Aktis Oncology, Inc. 08 Jan 2026 0 $0 3 10%+ Owner 08 Jan 2026, 21:05
HOWL Werewolf Therapeutics, Inc. 02 Dec 2025 3 -$183,275 4 Former 10% Owner 04 Dec 2025, 18:18
HOWL Werewolf Therapeutics, Inc. 26 Nov 2025 3 -$136,855 4 10%+ Owner 01 Dec 2025, 18:11
HOWL Werewolf Therapeutics, Inc. 21 Nov 2025 3 -$179,551 4 10%+ Owner 25 Nov 2025, 18:03
HOWL Werewolf Therapeutics, Inc. 18 Nov 2025 3 -$147,913 4 10%+ Owner 20 Nov 2025, 17:50
HOWL Werewolf Therapeutics, Inc. 13 Nov 2025 3 -$200,665 4 10%+ Owner 17 Nov 2025, 19:20
HOWL Werewolf Therapeutics, Inc. 07 Nov 2025 4 -$241,278 4 10%+ Owner 12 Nov 2025, 19:31
HOWL Werewolf Therapeutics, Inc. 04 Nov 2025 3 -$295,781 4 10%+ Owner 06 Nov 2025, 19:40
HOWL Werewolf Therapeutics, Inc. 30 Oct 2025 3 -$391,636 4 10%+ Owner 03 Nov 2025, 19:07
HOWL Werewolf Therapeutics, Inc. 27 Oct 2025 3 -$446,403 4 10%+ Owner 29 Oct 2025, 19:21
ITOS iTeos Therapeutics, Inc. 13 May 2025 1 -$8,317,364 4 Former 10% Owner 15 May 2025, 17:34
HOWL Werewolf Therapeutics, Inc. 27 Mar 2025 4 -$26.73 4 10%+ Owner 30 Apr 2025, 16:08
TCRR TCR2 THERAPEUTICS INC. 01 Jun 2023 3 $0 4 Director, 10%+ Owner 05 Jun 2023, 16:35
TCRR TCR2 THERAPEUTICS INC. 22 May 2023 4 -$0.54 4 Director, 10%+ Owner 24 May 2023, 16:38
ALVR Allovir, Inc. 28 Jul 2022 1 +$15,000,000 4 Director, 10%+ Owner 01 Aug 2022, 16:34
CGEM Cullinan Oncology, Inc. 22 Jun 2022 1 $0 4 Director 23 Jun 2022, 18:22
ALVR Allovir, Inc. 17 May 2022 1 $0 4 Director, 10%+ Owner 19 May 2022, 16:27
ITOS iTeos Therapeutics, Inc. 04 Jan 2022 5 -$10,452,334 4 10%+ Owner 06 Jan 2022, 15:12
CGEM Cullinan Oncology, Inc. 31 Dec 2021 3 +$1,509,033 5 Former Director, 10%+ Owner 10 Feb 2023, 15:26
ITOS iTeos Therapeutics, Inc. 03 Dec 2021 9 -$2,812,428 4 10%+ Owner 07 Dec 2021, 17:33
ITOS iTeos Therapeutics, Inc. 30 Nov 2021 7 -$4,817,417 4 10%+ Owner 02 Dec 2021, 17:53
ITOS iTeos Therapeutics, Inc. 26 Nov 2021 4 -$1,356,825 4 10%+ Owner 30 Nov 2021, 15:49
ITOS iTeos Therapeutics, Inc. 17 Nov 2021 8 -$4,744,666 4 10%+ Owner 24 Nov 2021, 17:38
ITOS iTeos Therapeutics, Inc. 15 Oct 2021 3 -$785,384 4 10%+ Owner 18 Oct 2021, 16:33
ITOS iTeos Therapeutics, Inc. 12 Oct 2021 3 -$2,584,606 4 10%+ Owner 14 Oct 2021, 17:26
ITOS iTeos Therapeutics, Inc. 07 Oct 2021 3 -$2,368,800 4 10%+ Owner 12 Oct 2021, 16:33
ITOS iTeos Therapeutics, Inc. 01 Oct 2021 2 -$1,247,590 4 10%+ Owner 05 Oct 2021, 16:31
ITOS iTeos Therapeutics, Inc. 28 Sep 2021 2 -$971,730 4 10%+ Owner 30 Sep 2021, 17:05
ITOS iTeos Therapeutics, Inc. 23 Sep 2021 4 -$2,484,094 4 10%+ Owner 27 Sep 2021, 17:51
ITOS iTeos Therapeutics, Inc. 21 Sep 2021 2 -$1,561,394 4 10%+ Owner 23 Sep 2021, 16:18
CGEM Cullinan Oncology, Inc. 16 Sep 2021 1 $0 4 Director, 10%+ Owner 25 Mar 2022, 19:32
ITOS iTeos Therapeutics, Inc. 16 Sep 2021 4 -$4,334,452 4 10%+ Owner 20 Sep 2021, 18:30
CGEM Cullinan Oncology, Inc. 16 Sep 2021 2 -$103,337 4 Director, 10%+ Owner 20 Sep 2021, 17:30
ITOS iTeos Therapeutics, Inc. 14 Sep 2021 4 -$2,116,733 4 10%+ Owner 16 Sep 2021, 16:46
CGEM Cullinan Oncology, Inc. 14 Sep 2021 4 -$449,174 4 Director, 10%+ Owner 16 Sep 2021, 16:44
ITOS iTeos Therapeutics, Inc. 09 Sep 2021 4 -$2,731,460 4 10%+ Owner 13 Sep 2021, 19:02
CGEM Cullinan Oncology, Inc. 09 Sep 2021 6 -$773,720 4 Director, 10%+ Owner 13 Sep 2021, 18:22
ITOS iTeos Therapeutics, Inc. 07 Sep 2021 4 -$2,067,786 4 10%+ Owner 08 Sep 2021, 19:19
CGEM Cullinan Oncology, Inc. 03 Sep 2021 6 -$1,616,749 4 Director, 10%+ Owner 08 Sep 2021, 18:17
CGEM Cullinan Oncology, Inc. 31 Aug 2021 8 -$816,352 4 Director, 10%+ Owner 02 Sep 2021, 17:25
CGEM Cullinan Oncology, Inc. 27 Aug 2021 4 -$1,476,135 4 Director, 10%+ Owner 31 Aug 2021, 16:48
CGEM Cullinan Oncology, Inc. 23 Aug 2021 6 -$3,531,820 4 Director, 10%+ Owner 25 Aug 2021, 19:41
CGEM Cullinan Oncology, Inc. 11 Aug 2021 2 -$82,996 4 Director, 10%+ Owner 12 Aug 2021, 16:54
RPTX Repare Therapeutics Inc. 09 Jul 2021 3 -$2,082,868 4 10%+ Owner 13 Jul 2021, 16:21
RPTX Repare Therapeutics Inc. 28 Jun 2021 3 -$653,925 4 10%+ Owner 30 Jun 2021, 17:25
RPTX Repare Therapeutics Inc. 24 Jun 2021 2 -$961,457 4 10%+ Owner 28 Jun 2021, 16:07
RPTX Repare Therapeutics Inc. 21 Jun 2021 5 -$1,470,441 4 10%+ Owner 23 Jun 2021, 17:38
RPTX Repare Therapeutics Inc. 17 Jun 2021 4 -$1,402,002 4 10%+ Owner 21 Jun 2021, 16:06
RPTX Repare Therapeutics Inc. 14 Jun 2021 2 -$207,066 4 10%+ Owner 16 Jun 2021, 17:09
RPTX Repare Therapeutics Inc. 08 Jun 2021 4 -$2,091,457 4 10%+ Owner 10 Jun 2021, 16:04
RPTX Repare Therapeutics Inc. 03 Jun 2021 6 -$1,861,612 4 10%+ Owner 07 Jun 2021, 18:39
HARP Harpoon Therapeutics, Inc. 28 May 2021 5 -$1,186,190 4 10%+ Owner 02 Jun 2021, 18:09
RPTX Repare Therapeutics Inc. 28 May 2021 4 -$1,237,042 4 10%+ Owner 02 Jun 2021, 17:39
HARP Harpoon Therapeutics, Inc. 26 May 2021 2 -$346,938 4 10%+ Owner 27 May 2021, 19:40
RPTX Repare Therapeutics Inc. 25 May 2021 6 -$1,265,633 4 10%+ Owner 27 May 2021, 19:41
ALVR Allovir, Inc. 25 May 2021 1 $0 4 Director, 10%+ Owner 27 May 2021, 16:57
RPTX Repare Therapeutics Inc. 21 May 2021 3 -$11,290,421 4 10%+ Owner 24 May 2021, 20:12
HARP Harpoon Therapeutics, Inc. 21 May 2021 2 -$321,030 4 10%+ Owner 24 May 2021, 20:11
RPTX Repare Therapeutics Inc. 18 May 2021 8 -$1,611,964 4 10%+ Owner 20 May 2021, 19:56
HARP Harpoon Therapeutics, Inc. 18 May 2021 3 -$982,227 4 10%+ Owner 20 May 2021, 19:20
HARP Harpoon Therapeutics, Inc. 13 May 2021 3 -$329,314 4 10%+ Owner 17 May 2021, 17:23
HARP Harpoon Therapeutics, Inc. 10 May 2021 5 -$1,436,556 4 10%+ Owner 12 May 2021, 18:09